Trial Design and Baseline Characteristics from REMODEL: A Mechanistic Study of Semaglutide vs. Placebo in People with Type 2 Diabetes and CKD
| Autor: | Cherney, David, Bjornstad, Petter, Chacko, Milenta Mariam, Gunnarsson, Thomas P., Hodgin, Jeffrey B., Kretzler, Matthias, Belmar, Nicolas, Pruijm, Menno, Schytz, Philip Andreas, Tuttle, Katherine R. |
|---|---|
| Zdroj: | Journal of the American Society of Nephrology; October 2024, Vol. 35 Issue: 10, Number 10 Supplement 10 |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|